Richard Furie, MD, surveys changes he has witnessed to the therapeutic landscape for the treatment of systemic lupus erythematosus (SLE), including the introduction of agents such as hydroxychloroquine and mycophenolate, belimumab, anifrolumab, and voclosporin.
Dr Furie contends that extended research supported the development of the current treatments for SLE, and that the arrival of new therapies will be made possible by continued advances in the understanding of the immune system.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Systemic Lupus Erythematosus: Unraveling the Immune System - Medscape - Jul 11, 2022.